0000000000496993

AUTHOR

C. Mao

showing 2 related works from this author

Comparison of the subjective satisfaction of the donor site morbidity : free radial forearm flap versus anterolateral thigh flap for reconstruction i…

2018

Background The purpose of the study was to compare the differences of the subjective satisfaction of the donor site morbidity between the free radial forearm flap (FRFF) and anterolateral thigh flap (ALTF) for tongue reconstruction. Material and Methods One hundred and nineteen patients underwent FRFF or ALTF reconstruction were retrospectively evaluated by a standardized self-established donor site morbidity questionnaire which included 5 domains, sensibility, movement disabilities, cosmetics, social activities and general impacts on the quality of life. Results The Cronbach’s coefficient alpha of the questionnaire was 0.707. The exploratory factor analysis revealed that the 5 items of the…

AdultMalemedicine.medical_specialtySurgical Flaps03 medical and health sciencesYoung Adult0302 clinical medicinePatient satisfactionPostoperative ComplicationsQuality of lifeCronbach's alphaTongueTongueSurveys and QuestionnairesmedicineHumansGeneral DentistryAgedRetrospective StudiesRadial forearm flapbusiness.industryResearchCancerReproducibility of ResultsRetrospective cohort study030206 dentistryAnterolateral thighMiddle AgedPlastic Surgery Proceduresmedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryTongue NeoplasmsForearmmedicine.anatomical_structureOtorhinolaryngologyThighPatient SatisfactionUNESCO::CIENCIAS MÉDICASQuality of LifeSurgeryFemaleMorbidityOral Surgerybusiness
researchProduct

TH-302 + Gemcitabine (G + T) vs Gemcitabine (G) in Patients with Previously Untreated advanced Pancreatic Cancer (PAC)

2012

ABSTRACT Background TH-302 is a hypoxia targeted prodrug with a hypoxia-triggered 2-nitroimidazole component designed to release the DNA alkylator, bromo-isophosphoramide mustard (Br-IPM), when reduced in severe hypoxia. A randomized Phase 2B study (NCT01144455) was conducted to assess the benefit of G + T to standard dose G as first-line therapy of PAC. Materials and methods An open-label multi-center study of two dose levels of TH-302 (240 mg/m2 or 340 mg/m2) in combination with G versus G alone (randomized 1:1:1). G (1000 mg/m2) and T were administered IV over 30-60 minutes on Days 1, 8 and 15 of a 28-day cycle. Patients on the G could crossover after progression and be randomized to a G…

medicine.medical_specialtyGastrointestinal tumorsPerformance statusbusiness.industryHematologySevere hypoxiaNeutropeniamedicine.diseaseRashGastroenterologyDiscontinuationNon colorectalOncologyInternal medicineToxicitymedicinemedicine.symptombusinessAnnals of Oncology
researchProduct